Screening Adults for Type 2 Diabetes: A Review of the Evidence for the U.S. Preventive Services Task Force
- Russell Harris, MD, MPH;
- Katrina Donahue, MD, MPH;
- Saif S. Rathore, MPH;
- Paul Frame, MD;
- Steven H. Woolf, MD, MPH; and
- Kathleen N. Lohr, PhD
-
From University of North Carolina at Chapel Hill, Chapel Hill, and Research Triangle Institute, Research Triangle Park, North
Carolina; Yale University Medical School, New Haven, Connecticut; Tri-County Family Medicine, Cohocton, New York; and Virginia
Commonwealth University, Fairfax, Virginia.
-
Appendix (Figure 1). Analytic framework for screening for type 2 diabetes. KQ = key question.
-
Appendix (Figure 2). Selection of articles based on key question 1. RCT = randomized, controlled trial.
-
Appendix (Figure 3). Selection of articles based on key question 2. RCT = randomized, controlled trial.
-
Appendix (Figure 4). Selection of articles based on key question 3.
-
Appendix (Figure 5). Selection of articles based on key question 4. RCT = randomized, controlled trial.
-
Appendix (Figure 6). Selection of articles based on key question 5.
- Copyright ©2004 by the American College of Physicians
-
Ann Intern Med
February 4, 2003
vol. 138
no. 3
215-229
RSS Feeds
View larger version:Appendix (Figure 1). Analytic framework for screening for type 2 diabetes. KQ = key question.
View larger version:Appendix (Figure 2). Selection of articles based on key question 1. RCT = randomized, controlled trial.
View larger version:Appendix (Figure 3). Selection of articles based on key question 2. RCT = randomized, controlled trial.
View larger version:Appendix (Figure 4). Selection of articles based on key question 3.
View larger version:Appendix (Figure 5). Selection of articles based on key question 4. RCT = randomized, controlled trial.
View larger version:Appendix (Figure 6). Selection of articles based on key question 5.
Related Clinical Content
